New Key Statistics Module, Z-Score and F-Score
NAS:TXMD Key Ratios
| Market Cap $ M | 24.68 |
| Enterprise Value $ M | 28.14 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.86 |
| Price/Sales | 19.45 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -0.68 |
| Beneish M-Score | 79.5 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -129.10 |
| EV-to-EBIT | -3.98 |
| EV-to-EBITDA | -4.66 |
| PEG | -- |
| Shares Outstanding M | 11.53 |
| Net Margin (%) | -617.93 |
| Operating Margin % | -583.65 |
| Pre-tax Margin (%) | -520.52 |
| Quick Ratio | 1.78 |
| Current Ratio | 1.78 |
| ROA % (ttm) | -14.87 |
| ROE % (ttm) | -24.83 |
| ROIC % (ttm) | -18.23 |
| Dividend Yield % | -- |
| Altman Z-Score | -30.82 |
TXMD Number of Guru Trades
TXMD Volume of Guru Trades
Gurus Latest Trades with NAS:TXMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TXMD is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TherapeuticsMD Inc Insider Transactions
No Available Data
News about NAS:TXMD
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers